Genic Co. Ltd (123330) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genic Co. Ltd (123330) has a cash flow conversion efficiency ratio of -0.026x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.43 Billion ≈ $-972.29K USD) by net assets (₩55.79 Billion ≈ $37.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Genic Co. Ltd (123330) market capitalisation for the company's overall valuation and market capitalisation.
Genic Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Genic Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Genic Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genic Co. Ltd ranked by their cash flow conversion efficiency. Explore Genic Co. Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Biosyent Inc.
V:RX
|
0.069x |
|
Sigachi Industries Limited
NSE:SIGACHI
|
-0.138x |
|
Smith-Midland Corp
NASDAQ:SMID
|
-0.009x |
|
Endeavour Mining Corp
LSE:EDV
|
0.087x |
|
Digital Multimedia Technology Co.Ltd
KQ:134580
|
0.112x |
|
Siam Pan Group PCL
BK:SPG
|
0.014x |
|
DongWon Development Co.Ltd
KQ:013120
|
-0.017x |
|
Shriram Properties Limited
NSE:SHRIRAMPPS
|
0.003x |
Annual Cash Flow Conversion Efficiency for Genic Co. Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Genic Co. Ltd from 2012 to 2025. View Genic Co. Ltd (123330) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩41.05 Billion ≈ $27.82 Million |
₩20.65 Billion ≈ $13.99 Million |
0.503x | +3990.77% |
| 2024-12-31 | ₩22.15 Billion ≈ $15.01 Million |
₩272.46 Million ≈ $184.64K |
0.012x | +152.86% |
| 2023-12-31 | ₩11.53 Billion ≈ $7.81 Million |
₩-268.31 Million ≈ $-181.83K |
-0.023x | -308.47% |
| 2022-12-31 | ₩15.94 Billion ≈ $10.80 Million |
₩177.94 Million ≈ $120.59K |
0.011x | -93.52% |
| 2021-12-31 | ₩19.30 Billion ≈ $13.08 Million |
₩3.32 Billion ≈ $2.25 Million |
0.172x | +1708.60% |
| 2020-12-31 | ₩22.33 Billion ≈ $15.13 Million |
₩212.66 Million ≈ $144.12K |
0.010x | -81.23% |
| 2019-12-31 | ₩27.14 Billion ≈ $18.39 Million |
₩1.38 Billion ≈ $933.12K |
0.051x | +122.19% |
| 2018-12-31 | ₩38.94 Billion ≈ $26.39 Million |
₩-8.90 Billion ≈ $-6.03 Million |
-0.229x | -203.64% |
| 2017-12-31 | ₩54.27 Billion ≈ $36.78 Million |
₩-4.09 Billion ≈ $-2.77 Million |
-0.075x | -342.20% |
| 2016-12-31 | ₩61.93 Billion ≈ $41.97 Million |
₩1.93 Billion ≈ $1.30 Million |
0.031x | -50.31% |
| 2015-12-31 | ₩58.04 Billion ≈ $39.33 Million |
₩3.63 Billion ≈ $2.46 Million |
0.063x | -40.55% |
| 2014-12-31 | ₩55.16 Billion ≈ $37.38 Million |
₩5.80 Billion ≈ $3.93 Million |
0.105x | +52.34% |
| 2013-12-31 | ₩53.25 Billion ≈ $36.08 Million |
₩3.68 Billion ≈ $2.49 Million |
0.069x | -15.26% |
| 2012-12-31 | ₩52.87 Billion ≈ $35.83 Million |
₩4.31 Billion ≈ $2.92 Million |
0.082x | -- |
About Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more